|
Harvey LH, Branch-Elliman W, Boudreau J, Sliwinski SK, Gifford AL, Ho MQ, Dinges E, Hyde J.
"Harm reduction stories: leveraging graphic medicine to engage veterans in substance use services within the VA." Harm Reduction Journal, vol. 20, no. 1, 2023, pp. 177.
|
|
Harvey L, Kimmel SD, Edelman EJ.
"Meeting the Moment: More Infectious Disease Physicians Must Be Prepared to Provide Buprenorphine." Clinical Infectious Diseases, vol. 76, no. 7, 2023, pp. 1205-1208.
|
|
Harvey LH, Sliwinski SK, Flike K, Boudreau J, Gifford AL, Branch-Elliman W, Hyde J.
"The integration of harm reduction services in the Veterans Health Administration (VHA): a qualitative analysis of barriers and facilitators." Journal of addictive diseases, 2023, pp. 1-9.
|
|
Harvey L, Rybak N, Rich J.
"The urgent need for opioid agonist treatment in Russia." The Lancet HIV, vol. 10, no. 9, 2023, pp. e559-e560.
|
|
Harvey LH, Green TC, Park JN, Rich JD.
"Xylazine in the drug supply: A research agenda." International Journal of Drug Policy, vol. 120, 2023, pp. 104190.
|
|
Khan GK, Harvey L, Johnson S, Long P, Kimmel S, Pierre C, Drainoni ML.
"Integration of a community-based harm reduction program into a safety net hospital: a qualitative study." Harm Reduction Journal, vol. 19, no. 1, 2022, pp. 35.
|
|
Harvey L, Boudreau J, Sliwinski SK, Strymish J, Gifford AL, Hyde J, Linsenmeyer K, Branch-Elliman W.
"Six Moments of Infection Prevention in Injection Drug Use: An Educational Toolkit for Clinicians." Open Forum Infectious Diseases, vol. 9, no. 2, 2022, pp. ofab631.
|
|
Harvey L, Taylor JL, Assoumou SA, Kehoe J, Schechter-Perkins EM, Bernstein E, Walley AY.
"Sexually Transmitted and Blood-borne Infections Among Patients Presenting to a Low-barrier Substance Use Disorder Medication Clinic." Journal of Addiction Medicine, vol. 15, no. 6, 2021, pp. 461-467.
|
